ATC code M02

ATC code M02 Topical products for joint and muscular pain is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.^[1]^[2]^[3] Subgroup M02 is part of the anatomical group M Musculo-skeletal system.^[4]

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QM02.^[5] ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

M02A Topical products for joint and muscular pain

M02AA Anti-inflammatory preparations, non-steroids for topical use

M02AA01 Phenylbutazone

M02AA02 Mofebutazone

M02AA03 Clofezone

M02AA04 Oxyphenbutazone

M02AA05 Benzydamine

M02AA06 Etofenamate

M02AA07 Piroxicam

M02AA08 Felbinac

M02AA09 Bufexamac

M02AA10 Ketoprofen

M02AA11 Bendazac

M02AA12 Naproxen

M02AA13 Ibuprofen

M02AA14 Fentiazac

M02AA15 Diclofenac

M02AA16 Feprazone

M02AA17 Niflumic acid

M02AA18 Meclofenamic acid

M02AA19 Flurbiprofen

M02AA21 Tolmetin

M02AA22 Suxibuzone

M02AA23 Indometacin

M02AA24 Nifenazone

M02AA25 Aceclofenac

M02AA26 Nimesulide

M02AA27 Dexketoprofen

M02AA28 Piketoprofen

M02AA29 Esflurbiprofen

M02AA31 Loxoprofen

QM02AA99 Antiinflammatory preparations, non-steroids for topical use, combinations

M02AB Capsaicin and similar agents

M02AB01 Capsaicin

M02AB02 Zucapsaicin

M02AC Preparations with salicylic acid derivatives

QM02AC99 Preparations with salicylic acid derivatives, combinations

QM02AQ Blistering agents

M02AX Other topical products for joint and muscular pain

M02AX02 Tolazoline

M02AX03 Dimethyl sulfoxide

M02AX05 Idrocilamide

M02AX06 Tolperisone

M02AX10 Various

QM02AX53 Dimethyl sulfoxide, combinations

References

^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
^ World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
^ "ATC/DDD Index 2022: code M02". WHO Collaborating Centre for Drug Statistics Methodology.
^ "ATCvet Index 2022: code QM02". WHO Collaborating Centre for Drug Statistics Methodology.

[1] "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.

[2] World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.

[3] "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.

[4] "ATC/DDD Index 2022: code M02". WHO Collaborating Centre for Drug Statistics Methodology.

[5] "ATCvet Index 2022: code QM02". WHO Collaborating Centre for Drug Statistics Methodology.

[1]

[2]

[3]

[4]

[5]

v t e Non-steroidal anti-inflammatory drugs (NSAIDs) (primarily M01A and M02A, also N02BA)
pyrazolones / pyrazolidines	Aminophenazone Ampyrone Azapropazone Clofezone Difenamizole Famprofazone Feprazone Kebuzone Metamizole Mofebutazone Morazone Nifenazone Oxyphenbutazone Phenazone Phenylbutazone Propyphenazone Sulfinpyrazone Suxibuzone^‡
salicylates	Aspirin (acetylsalicylic acid)^# Aloxiprin Benorylate Carbasalate calcium Diflunisal Dipyrocetyl Ethenzamide Guacetisal Magnesium salicylate Methyl salicylate Salsalate Salicin Salicylamide Salicylic acid (salicylate) Sodium salicylate
acetic acid derivatives and related substances	Aceclofenac Acemetacin Alclofenac Amfenac Bendazac Bromfenac Bufexamac Bumadizone Diclofenac Difenpiramide Etodolac Felbinac Fenclozic acid Fentiazac Indometacin Indometacin farnesil Isoxepac Ketorolac Lonazolac Mofezolac Oxametacin Prodolic acid Proglumetacin Sulindac Tiopinac Tolmetin Zomepirac^†
oxicams	Ampiroxicam Droxicam Isoxicam Lornoxicam Meloxicam Piroxicam Pivoxicam Tenoxicam
propionic acid derivatives (profens)	Alminoprofen Benoxaprofen^† Carprofen^‡ Dexibuprofen Dexketoprofen Fenbufen Fenoprofen Flunoxaprofen Flurbiprofen Ibuprofen^# Ibuproxam Indoprofen^† Ketoprofen Loxoprofen Miroprofen Naproxen Oxaprozin Pelubiprofen Piketoprofen Pirprofen Suprofen Tarenflurbil Tepoxalin^‡ Tiaprofenic acid Vedaprofen^‡ Zaltoprofen COX-inhibiting nitric oxide donator: Naproxcinod
n-arylanthranilic acids (fenamates)	Azapropazone Clonixin Etofenamate Floctafenine Flufenamic acid Flunixin Flutiazin Glafenine^† Meclofenamic acid Mefenamic acid Morniflumate Niflumic acid Tolfenamic acid
COX-2 inhibitors (coxibs)	Apricoxib Celecoxib (+tramadol) Cimicoxib^‡ Deracoxib^‡ Etoricoxib Firocoxib^‡ Lumiracoxib^† Mavacoxib^‡ Parecoxib Robenacoxib^‡ Rofecoxib^† Valdecoxib^†
other	Aminopropionitrile Benzydamine Chondroitin sulfate Diacerein Fluproquazone Glucosamine Glycosaminoglycan Hyperforin Nabumetone Nimesulide Oxaceprol Proquazone Superoxide dismutase / orgotein Tenidap
NSAID combinations	Ibuprofen/famotidine Ibuprofen/hydrocodone Ibuprofen/oxycodone Ibuprofen/paracetamol Meloxicam/bupivacaine Naproxen/diphenhydramine Naproxen/esomeprazole
Key: underline indicates initially developed first-in-class compound of specific group; ^#WHO-Essential Medicines; ^†withdrawn drugs; ^‡veterinary use.
category commons portal